Cantor Fitzgerald Maintains Overweight on Eli Lilly, Raises Price Target to $1350

Benzinga Newsdesk www.benzinga.com Positive 80.1%

Neg 0% Neu 0% Pos 80.1%

Cantor Fitzgerald analyst Carter Gould maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1230 to $1350.